Kolexia
Terrebonne Eric Gastro-entérologie
Terrebonne Eric
Gastro-entérologie
Hôpital Haut-lévêque
Pessac, France
116 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Adénocarcinome Tumeurs du pancréas Tumeurs colorectales Métastase tumorale Récidive tumorale locale Tumeurs de l'oesophage Carcinomes Tumeurs neuroendocrines Tumeurs de l'estomac

Collaborateurs

Voir plus
Smith Denis
Smith Denis
Hôpital Saint-André, Bordeaux, France
Blanc Jean-Frederic
Blanc Jean-Frederic
Hôpital Saint-André, Bordeaux, France
Lecaille Cedric
Lecaille Cedric
Hôpital Privé Saint-Martin, Pessac, France
Lecomte Thierry
Lecomte Thierry
Hôpital Trousseau Chambray lès Tours, Chambray-lès-Tours, France

Industries

Voir plus
B3TSI
50 collaboration(s)
Dernière en 2023
Ipsen
19 collaboration(s)
Dernière en 2022
A+A
14 collaboration(s)
Dernière en 2023
Servier
9 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter study.
JNCI cancer spectrum   23 octobre 2023
OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogel.
European journal of endocrinology   01 septembre 2023
POCHI: Pembrolizumab in Combination With Xelox Bevacizumab in Patients With Microsatellite Stable Mestatic Colorectal Cancer and a High Immune Infiltrate : a Proof of Concept Study
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
OSCAR: Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
PVTE: Prognosis Value of Transient Elastography and Non-invasive Markers of Fibrosis in Patients With Chronic Liver Disease. A Prospective Follow-up of 4,935 Person-years
Essai Clinique (CHU Bordeaux)   19 juillet 2023
Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   14 septembre 2022
LBA28 Prognostic effect of imaging and CEA follow-up in resected colorectal cancer (CRC): Final results and relapse free survival (RFS) - PRODIGE 13 a FFCD phase III trial
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer.
European journal of cancer (Oxford, England : 1990)   01 juillet 2022
Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy: A multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study).
2022 ASCO Annual Meeting I   02 juin 2022
AMEBICA: Randomised Phase II/III Study, Assessing the Safety and Efficacy of Modified Folfirinox Versus Gemcis in Locally Advanced, Unresectable and/or Metastatic Bile Duct Tumours
Essai Clinique (CHU Saint-Étienne)   23 février 2022